Market Shrugs Off This Drugmaker’s Turnaround

All NewsMay 15, 2025

This drugmaker achieved a milestone – its first quarterly profit. But the stock is down despite the good tidings.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent